Status:
COMPLETED
A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Osteoporosis
Eligibility:
FEMALE
45-79 years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to study the clinical safety, tolerability, and efficacy of zoledronic acid compared to an oral bisphosphonate in postmenopausal women with osteoporosis.
Eligibility Criteria
Inclusion
- Postmenopausal women between 45 and 79 years of age
- Must be osteopenic/osteoporotic
Exclusion
- Any women of child-bearing potential
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00100555
Start Date
June 1 2004
End Date
June 1 2005
Last Update
April 27 2012
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Univ. of Alabama/Division of Clinical Immunology and Rheumatology
Birmingham, Alabama, United States, 35294
2
Radiant Research
San Diego, California, United States, 92108
3
Denver Arthritis Clinic
Denver, Colorado, United States, 80230
4
Florida Medical Research Institute
Gainesville, Florida, United States, 32605